Benzinga's Top #PreMarket Losers

Endocyte

dipped 19.95% to $6.18 in pre-market trading after the company reported that the company has regained global rights to vintafolide. La-Z-Boy

dropped 9.22% to $22.55 in pre-market trading after the company reported downbeat fourth-quarter revenue. The company also announced its plans to stop production at Hudson plant this year. Its same-store sales declined 0.9% in the quarter, versus an 11.2% gain in the year-ago quarter. GW Pharmaceuticals plc

shares dropped 4.10% to $86.14 in pre-market trading after the company announced an offering of 1.7 million ADSs. Achillion Pharmaceuticals

shares fell 3.69% to $7.30 in pre-market trading after dropping 3.07% on Tuesday.